logo
  

Crimson Tide Signs Master Service Deal For Compass Group's Non-UK Operations; Stock Up

Crimson Tide Plc (TIDE.L), the provider of the mpro5 solution, announced Tuesday that it has entered into a Master Services Agreement or MSA with food service company Compass Group (CPG.L,CMPGF.PK) for its non-UK based operations.

The company said the contract underpins opportunities for future sales of mpro5 to Compass Group's operations across 45 countries in over 55,000 locations.

Following the MSA, Crimson Tide announced its first contract with Compass Group's Danish operations. Following an initial pilot project, this deployment reflects an expanded number of users and wider use of mpro5 to include Compass' first IoT enabled sites.

Barrie Whipp, Chairman said, "We have proved the value of mpro5 with Compass Group in the UK over a number of years. This Master Service Agreement allows other Compass locations to easily add mpro5 to their operations to enjoy the great benefits in food safety and compliance that our solution affords."

In London, Crimson Tide shares were trading at 2.90 pence, up 3.61 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MTD Products Inc. is recalling 1,774 units of walk-behind self-propelled lawn mowers for potential risk of fire hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the lawn mower can leak fuel when it is stored in the upright (vertical) storage position to pose a fire hazard. Nike Inc. announced its plans to exit the Russian market completely following Russia's ongoing war against Ukraine, reports said. The sportswear major, with more than 100 stores in the country, had suspended operations there in March. Earlier in March, while suspending operations temporarily, the company had said its customers that it couldn't guarantee product shipments. The U.S. Food and Drug Administration unveiled its action plan to advance drug development for rare neurodegenerative diseases, including Amyotrophic Lateral Sclerosis or ALS, in five years. The FDA plans specific actions such as regulatory science initiatives, enhancements to existing programs and new policy initiatives for the purpose. It will use public-private partnerships...
Follow RTT